# FDA Inspection 1231826 - Rubicon Research Private Limited - March 08, 2024

Source: https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/f00f8404-7177-4b65-bf89-298c4f087c92
Source feed: FDA_Inspections

> FDA Inspection 1231826 for Rubicon Research Private Limited on March 08, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231826
- Company Name: Rubicon Research Private Limited
- Inspection Date: 2024-03-08
- Classification: No Action Indicated (NAI)
- Project Area: New Drug Evaluation
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1250746 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/282ae837-a9f2-4530-9fbd-abc9552a039b)
- [FDA Inspection 1250746 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/d82de48f-937f-40e0-9b08-0bc68dd01c69)
- [FDA Inspection 1250746 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/fa7fff64-103d-4cfa-acf9-e7905acaad8e)
- [FDA Inspection 1231826 - 2024-03-08](https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/294308ca-9e9c-45fc-8ac0-dd8d28cf4255)
- [FDA Inspection 1231826 - 2024-03-08](https://www.keypedia.com/records/fda_inspections/rubicon-research-private-limited/392edcd8-fab7-47dd-9fe1-aabb42c852dd)

Company: https://www.keypedia.com/companies/rubicon-research-private-limited/07d24fe7-deaa-4c5a-9fd3-9562d3cefd6f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c